Intermittent vancomycin dosing in noncritically ill adults
For intermittent vancomycin dosing in noncritically ill adults without obesity, an appropriate initial dosage is:
CrCl more than 60 mL/min: 15 mg/kg (actual body weight), rounded up to the nearest 125 mg, up to 2 g, 12-hourly. Maximum daily dose 4 g
CrCl 20 to 60 mL/min: 7.5 mg/kg (actual body weight), rounded up to the nearest 125 mg, up to 1 g, 12-hourly. Maximum daily dose 2 g
CrCl less than 20 mL/min: 15 mg/kg (actual body weight), rounded up to the nearest 125 mg, up to 2 g, as a single dose1.
For noncritically ill adults with obesity, it is the consensus view of the Antibiotic Expert Group that the initial vancomycin dosage should be the same as that for nonobese patients (as above).
For adults undergoing haemodialysis, see Vancomycin dosing, monitoring and dosage adjustment in adults undergoing dialysis.
Vancomycin monitoring is required if therapy continues for more than 48 hours. The maintenance dosage depends on the vancomycin plasma concentration. Monitoring and dose adjustment is essential for all patients receiving vancomycin to optimise drug exposure and minimise toxicity.
Consider switching to a continuous vancomycin infusion for patients who require higher or more frequent doses (eg patients with obesity, patients with central nervous system infection) or those admitted to an ambulatory antimicrobial therapy service.
Actual body weight: | |
Actual body weight: 40 kg or less | |
CrCl [NB2] |
Suggested dosage |
more than 60 mL/minute |
15 mg/kg (actual body weight) 12-hourly |
20 to 60 mL/minute |
7.5 mg/kg (actual body weight) 12-hourly |
less than 20 mL/minute and not treated with dialysis |
15 mg/kg (actual body weight) as a single dose [NB3] |
Actual body weight: 41 to 50 kg | |
CrCl [NB2] |
Suggested dosage |
more than 60 mL/minute |
750 mg 12-hourly |
20 to 60 mL/minute |
375 mg 12-hourly |
less than 20 mL/minute and not treated with dialysis |
750 mg as a single dose [NB3] |
Actual body weight: 51 to 60 kg | |
CrCl [NB2] |
Suggested dosage |
more than 60 mL/minute |
1 g 12-hourly |
20 to 60 mL/minute |
500 mg 12-hourly |
less than 20 mL/minute and not treated with dialysis |
1 g as a single dose [NB3] |
Actual body weight: 61 to 80 kg | |
CrCl [NB2] |
Suggested dosage |
more than 60 mL/minute |
1.25 g 12-hourly |
20 to 60 mL/minute |
625 mg 12-hourly |
less than 20 mL/minute and not treated with dialysis |
1.25 g as a single dose [NB3] |
Actual body weight: 81 to 100 kg | |
CrCl [NB2] |
Suggested dosage |
more than 60 mL/minute |
1.5 g 12-hourly |
20 to 60 mL/minute |
750 mg 12-hourly |
less than 20 mL/minute and not treated with dialysis |
1.5 g as a single dose [NB3] |
Actual body weight: 101 to 120 kg | |
CrCl [NB2] |
Suggested dosage |
more than 60 mL/minute |
1.75 g 12-hourly |
20 to 60 mL/minute |
875 mg 12-hourly |
less than 20 mL/minute and not treated with dialysis |
1.75 g as a single dose [NB3] |
Actual body weight: 121 kg or more | |
CrCl [NB2] |
Suggested dosage |
more than 60 mL/minute |
2 g 12-hourly |
20 to 60 mL/minute |
1 g 12-hourly |
less than 20 mL/minute and not treated with dialysis |
2 g as a single dose [NB3] |
Note:
CrCl = creatinine clearance NB1: The dosages in this table are for initial dosing only, up to 48 hours. Subsequent dosage adjustments should be based on plasma concentration monitoring. NB2: Use the Cockcroft–Gault formula or calculator to approximate creatinine clearance. NB3: For adults with creatinine clearance less than 20 mL/minute and not treated with dialysis, a single dose may be given. Measure the plasma concentration 48 hours after the dose. Seek expert advice to determine ongoing doses and dosing interval. |